Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,503 shares of Class A Common Stock at a price of $12.56 per share on April 29, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., reported a transaction involving the sale of company stock.
• On April 29, 2024, Boughton sold 2,503 shares of Class A Common Stock at a price of $12.56 per share.
• The sale was executed under a Rule 10b5-1 trading plan adopted by Boughton on September 8, 2023.
• Following the transaction, Boughton directly owns 161,860 shares of Hims & Hers Health, Inc.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a positive or negative outlook on the company's performance.

Industry Context

Sales by insiders are a common occurrence and are often pre-planned through Rule 10b5-1 trading plans to avoid accusations of trading on non-public information. The market typically analyzes the size and frequency of these sales to gauge insider sentiment.

Comparison to Industry Standards

• Insider sales are a normal part of corporate governance, with executives often holding significant equity as part of their compensation.
• Companies like Amazon, Apple, and Microsoft also see regular insider trading activity, often governed by similar 10b5-1 plans.
• The volume and frequency of insider sales are often compared to industry peers to assess whether the activity is typical or indicative of a larger trend.

Stakeholder Impact

• The sale of shares by a key executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates